APO-Pregabalin

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Pregabalin 50mg

Disponible depuis:

Apotex NZ Ltd

DCI (Dénomination commune internationale):

Pregabalin 50 mg

Dosage:

50 mg

forme pharmaceutique:

Capsule

Composition:

Active: Pregabalin 50mg Excipient: Gelatin   Lactose monohydrate Maize starch Purified talc Sodium laurilsulfate   Titanium dioxide   Water  

Type d'ordonnance:

Prescription

Fabriqué par:

Srini Pharmaceuticals Pvt Ltd

indications thérapeutiques:

Indicated for the treatment of neuropathic pain in adults.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, PVC/Al - 14 capsules - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 20 capsules - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 56 capsules - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 60 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with child resistant PP cap - 14 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with child resistant PP cap - 20 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with child resistant PP cap - 56 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with child resistant PP cap - 60 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PP cap - 100 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PP cap - 500 capsules - 24 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

2014-01-06